Further direct evidence for a role of NF-κB signalling in human PASMC was demonstrated in a study that associated a single nucleotide polymorphism in the TRPC gene promoter region with a functional NF-κB binding site in 268 patients with idiopathic PAH. Here, NFKB1 is linked to pulmonary arterial hypertension.